<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-103845</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Psoriasis: a Skin Disease Associated With Increased Cardiovascular Risk</dc:title>
<dc:description xml:lang="en">Psoriasis and psoriatic arthritis are associated with increased risk of cardiovascular events and cardiovascular mortality. Alongside classic risk factors such as atherosclerosis, the severity of psoriatic skin disease also influences cardiovascular risk in these patients. In both cases, endothelial dysfunction and increased intima-media thickness in the carotid artery are indicators of subclinical cardiovascular disease. Active treatment of the psoriasis and management of traditional cardiovascular risk factors are essential in order to reduce cardiovascular morbidity in these patients. Clinical practice guidelines on the management of cardiovascular risk will define a new integrated approach to the care of patients with psoriasis and psoriatic arthritis (AU)</dc:description>
<dc:creator>González-Juanatey, C</dc:creator>
<dc:creator>González-Gay, MA</dc:creator>
<dc:creator>González-Vela, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La psoriasis y la artritis psoriásica se asocian con un mayor riesgo de eventos cardiovasculares y de mortalidad cardiovascular. Además de los factores clásicos de aterosclerosis, la gravedad de la afección cutánea influye en el aumento del riesgo cardiovascular en estos pacientes. En ambos procesos se observa la presencia de disfunción endotelial y un grosor aumentado de la íntima-media de la arteria carótida, como expresión de enfermedad cardiovascular subclínica. El tratamiento activo de la enfermedad y el manejo de los factores de riesgo cardiovascular clásicos son fundamentales para disminuir la morbilidad cardiovascular en estos pacientes. El establecimiento de guías clínicas para el manejo del riesgo cardiovascular abrirá, en el futuro, un nuevo abordaje clínico integral del paciente con psoriasis y la artritis psoriásica (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;103(7): 595-598, sept. 2012.</dc:source>
<dc:identifier>ibc-103845</dc:identifier>
<dc:title xml:lang="es">Psoriasis: una enfermedad cutánea relacionada con riesgo cardiovascular elevado</dc:title>
<dc:subject>^d33209</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2359^s22047</dc:subject>
<dc:subject>^d2359</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24527</dc:subject>
<dc:subject>^d50504</dc:subject>
<dc:subject>^d1178</dc:subject>
<dc:subject>^d24527^s22016</dc:subject>
<dc:subject>^d24527^s22047</dc:subject>
<dc:subject>^d24527^s22012</dc:subject>
<dc:subject>^d24527^s22067</dc:subject>
<dc:subject>^d24527^s22054</dc:subject>
<dc:type>article</dc:type>
<dc:date>201209</dc:date>
</metadata>
</record>
</ibecs-document>
